Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

Jong Hyun Park, Yeon Ha Ju, Ji Won Choi, Hyo Jung Song, Bo Ko Jang, Junsung Woo, Heejung Chun, Hyeon Jeong Kim, Su Jeong Shin, Oleg Yarishkin, Seonmi Jo, Mijeong Park, Seul Ki Yeon, Siwon Kim, Jeongyeon Kim, Min Ho Nam, Ashwini M. Londhe, Jina Kim, Sung Jin Cho, Suengmok ChoChangho Lee, Sung Yeoun Hwang, Sang Wook Kim, Soo Jin Oh, Jeiwon Cho, Ae Nim Pae, C. Justin Lee, Ki Duk Park

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease'. Together they form a unique fingerprint.

Medicine & Life Sciences